Jiangsu Jibeier Pharmaceutical Co Ltd (688566) — Capital Reinvestment Ratio
Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a Capital Reinvestment Ratio of 2.24x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥11.07 Million) in capital expenditures (CN¥24.80 Million). Check 688566 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Jibeier Pharmaceutical Co Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Jiangsu Jibeier Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Jiangsu Jibeier Pharmaceutical Co Ltd.
Annual Capital Reinvestment Ratio for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025. See 688566 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.46x | CN¥248.30 Million | CN¥114.60 Million | ▼ -43.1% |
| 2024 | 0.81x | CN¥215.29 Million | CN¥174.53 Million | ▼ -63.8% |
| 2023 | 2.24x | CN¥159.50 Million | CN¥357.37 Million | ▲ +15.4% |
| 2022 | 1.94x | CN¥150.72 Million | CN¥292.70 Million | ▲ +249.0% |
| 2021 | 0.56x | CN¥150.56 Million | CN¥83.79 Million | ▲ +175.8% |
| 2020 | 0.20x | CN¥117.36 Million | CN¥23.68 Million | ▼ -22.9% |
| 2019 | 0.26x | CN¥115.45 Million | CN¥30.22 Million | ▲ +212.9% |
| 2018 | 0.08x | CN¥97.97 Million | CN¥8.19 Million | ▼ -50.3% |
| 2017 | 0.17x | CN¥111.66 Million | CN¥18.78 Million | ▼ -85.8% |
| 2016 | 1.19x | CN¥39.29 Million | CN¥46.69 Million | — |